Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".
Mohamed S, Lucchini E, Sirianni F, Porrazzo M, Ballotta L, Ballerini M, De Sabbata GM, De Bellis E, Cappuccio I, Granzotto M, Toffoletto B, Fortunati I, Russignan A, Florea EE, Torelli L, Zaja F.
Mohamed S, et al. Among authors: torelli l.
Front Oncol. 2023 Feb 27;13:1133348. doi: 10.3389/fonc.2023.1133348. eCollection 2023.
Front Oncol. 2023.
PMID: 36923438
Free PMC article.